Brenmiller Energy has had a rough month. The stock has fallen 25% to $2.28 and carries a borrow cost well above its sector peers — yet short positioning has collapsed, and earnings are just two weeks away.
The most striking feature of the current setup is how sharply short interest has declined. SI now sits at roughly 1.4% of free float — down more than 90% over the past 30 days, from a peak above 400,000 shares in late March and early April to just 37,651 shares. That unwinding was dramatic: the short book shrank from over 390,000 shares to around 21,000 between April 9 and April 23, then held flat. Whatever drove that mass exit — whether a squeeze, a cover-the-loss decision, or position rebalancing — the aggressive short thesis has largely been abandoned. The ORTEX short score, at 46, is broadly neutral and has barely moved across the past two weeks, suggesting no fresh wave of shorting has built in response to the price weakness.
The lending market tells a more complex story. Cost to borrow came in at 21.6% annualised on May 7, down sharply from the week's open near 30% and well off the late-April peak around 39%. That's still an elevated rate for a micro-cap with so few shares short — and it points to tightness in the lending pool that goes beyond what the current SI level would normally justify. Availability, by contrast, reads at a loose 259% of short interest, meaning the pool of shares available to borrow is more than twice the size of current short positions. The combination of falling borrow cost, ample availability, and near-absent short interest means squeeze pressure is essentially non-existent right now.
The stock's own price action diverges from its closest correlated peers. BNRG dropped 11% on the week, a markedly worse outcome than NNE, which added 17%, and KULR, which gained nearly 6%. Even SMR edged up 3%. XPON suffered a similar week at -8%, so BNRG is not entirely alone in the selloff, but the relative underperformance against energy-adjacent small-caps is notable. With a market cap of just over $1 million, the stock is extremely thinly capitalised, which amplifies both the moves and the noise in any metric tied to share counts.
The institutional ownership picture is thin and largely stale. The largest disclosed holder is Alpha Capital Anstalt, with roughly 2.3% of shares as of September 2025. Founder Avraham Brenmiller reported a reduction of 2,941 shares as of March 2026, leaving him with 782 shares — a modest but visible trimming at the founder level. Insider trade data beyond that is too dated to carry analytical weight, so no conclusions should be drawn from the historical buy activity, which stretches back to 2021.
What matters most in the near term is the earnings event scheduled for May 22. The prior four prints show a mixed reaction pattern: a 5% gain the day after the March 2026 release quickly reversed into an 8% five-day loss; the September 2025 print fell 6% on day one and 10% over five days; and the December 2025 event dropped 1.7% on the day before collapsing 37% over the following week. The consistent theme is that multi-day reactions have been negative even when the initial print was positive. With the stock already down 25% in a month heading into the next release, how the market responds to the print on May 22 — and whether any short interest rebuilds ahead of it — will be the defining question for BNRG's near-term direction.
See the live data behind this article on ORTEX.
Open BNRG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
